Canaan Partners VIII LLC, Director, 10% Owner at Durata Therapeutics, Inc. (DRTX), bought 1,902,030 shares at $9.00 ($5.0M) on 2012-07-24, disclosed to the SEC on 2012-07-27.
Open-market purchase of $5.0M DRTX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,346,475 | $0 | 0.0% |
| 2 | $9.00 | 555,555 | $5.0M | 100.0% |
| Total | $2.63 avg | 1,902,030 | $5.0M | 100% |
| Filing → |
| LOV | SELL | 2021-07-13 | $19K | — | Filing → |
| LOV | SELL | 2021-06-16 | $112K | — | Filing → |
| LOV | SELL | 2021-06-09 | $223K | — | Filing → |